๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China flag China ยท Delayed Price ยท Currency is CNY
32.95
-1.74 (-5.02%)
Nov 20, 2026, 3:04 PM CST

SHE:300573 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,8072,4731,9431,4681,2501,028
Revenue Growth
16.57%27.24%32.42%17.42%21.59%49.26%
Gross Profit
2,2971,9951,5191,127979.78798.91
Operating Income
916.16810.48408.42259.93231.2240.31
Net Income
802.06695.86338.06240.04211.68194.7
Earnings Per Share
2.241.950.950.680.610.60
EPS Growth
23.86%105.08%40.00%12.33%1.17%120.43%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Manufacturing
2,3871,7911,089820.98706.67
Medical Service
66.1132.89350.93405.67317.44
Unallocated Other Operations
19.9219.4927.8623.23.81
Total
2,4731,9431,4681,2501,028

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
537.82393.71370.12480.42515.45686.36
Total Debt
105.5882.03215.3179.1513.81111.28
Net Cash (Debt)
432.24311.69154.81401.27501.64575.08
Net Cash Growth
76.00%101.33%-61.42%-20.01%-12.77%-
Net Cash Per Share
1.210.870.441.141.431.77

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
891.4753.39416.98317.57286.26306.96
Capital Expenditures
-277.5-270.53-198.71-261.96-299.23-95.06
Free Cash Flow
613.91482.86218.2755.61-12.96211.9
Free Cash Flow Growth
49.93%121.22%292.54%--1412.86%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
81.85%80.67%78.16%76.81%78.39%77.72%
Operating Margin
32.64%32.77%21.02%17.71%18.50%23.38%
Pretax Margin
32.73%32.36%20.33%18.06%18.70%23.69%
Profit Margin
28.58%28.14%17.39%16.36%16.94%18.94%
FCF Margin
21.87%19.53%11.23%3.79%-1.04%20.61%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.9901.1720.7391.3020.3770.163
Dividend Per Share Growth
10.88%58.67%-43.24%245.33%130.72%160.19%
Dividend Yield
3.00%2.42%2.15%2.03%1.20%0.51%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
14.6924.8936.1794.6352.3357.85
Forward PE
-24.6824.6862.6624.48-
P/FCF Ratio
19.0535.8756.03408.51-53.15
PS Ratio
4.177.016.2915.488.8610.96